All posts tagged
This French Biotech Wants to Reinvent DC-based Immunotherapies
Which EU Immuno-Oncology Company are you Cheering for?
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
More News! Lurid Pharma Stories, Money & Partnerships
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
These are 10 of the Hottest Biotech Hubs in Europe
Stories We Didn’t Cover: Malaria Vaccine Money, Diabetes FDA Approvals
Key German Hospital to start a Phase I trial in TCR Cell Therapy
11 Biotech Leaders you should meet in Munich
Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round
Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech
Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors
Labiotech UG, All Rights Reserved -
Send this to a friend